MedPath

Reducing Hippocampal Hyperactivity and Improving Cognition in Schizophrenia

Phase 1
Completed
Conditions
Schizophrenia
Registration Number
NCT03034356
Lead Sponsor
VA Office of Research and Development
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
67
Inclusion Criteria

Inclusion Criteria:<br><br> - Diagnosis of schizophrenia or schizoaffective disorder<br><br> - Good general health<br><br> - Normal vital signs (blood pressure, pulse, respiration)<br><br>Exclusion Criteria:<br><br> - Substance abuse<br><br> - Significant neurological disorders<br><br> - Significant head trauma/injury<br><br> - Pregnancy<br><br> - MRI-specific exclusion criteria, e.g.,:<br><br> - claustrophobia<br><br> - weight>400 lbs<br><br> - metal in the body

Exclusion Criteria

Not provided

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Neurocognitive function
Secondary Outcome Measures
NameTimeMethod
Resting-state neuronal response
© Copyright 2025. All Rights Reserved by MedPath